Intelligent Medicine Acquisition Corp.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Intelligent Medicine Acquisition Corp. generated cash of -$866,896, which is more than the previous year. Cash used in financing activities reached the amount of -$13,373 last year. Net change in cash is therefore -$539,123.
Cash Flow
| 2021 | -365.19B | -211.14T | 212.09T |
|---|---|---|---|
| 2022 | -866.89K | 341.14K | -13.37K |
IQMD Cash Flow Statement (2021 – 2022)
| 2022 | 2021 | |
|---|---|---|
Cash at beginning of period | 589.27K | 0 |
Operating activities | ||
Net income | 11.40M | 0 |
| Adjustments to reconcile net income to cash generated by operating activities: | ||
Depreciation and amortization | 0 | 0 |
Stock-based compensation expense | 0 | 0 |
| Deferred income tax benefit | 0 | 0 |
| Changes in operating assets and liabilities: | ||
Accounts receivable, net | 0 | 0 |
Inventories | 0 | 0 |
Accounts payable | 0 | 208.50B |
Cash generated by operating activities | -866.89K | -365.19B |
Investing activities | ||
Purchases Of Investments | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 |
Acquisitions Net | 0 | 0 |
Cash generated by investing activities | 341.14K | -211.14T |
Financing activities | ||
Common Stock Issued | 0 | 25B |
Payments for dividends | 0 | 0 |
Repurchases of common stock | 0 | 0 |
Repayments of term debt | 0 | 0 |
Cash used in financing activities | -13.37K | 212.09T |
Net Change In Cash | -539.12K | 589.27B |
Cash at end of period | 50.15K | 589.27B |
| Data source | Data source |